# Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient

> **NCT07140133** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Grenoble** · enrollment: 1200 (estimated)

## Conditions studied

- High Bleeding Risk Patients
- Cardiology
- Stent Implantation
- DAPT(Dual Antiplatelet Therapy)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07140133
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07140133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07140133, "Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07140133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*